Jia Zhong

10PUBLICATIONS
51CO-AUTHORS
Molecular targetsMedical mycologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 12, 2026
Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study.

Jian-Chun Duan, Jia Zhong, Bo-Yang Sun

|Feb 13, 2025
A Multi-Center Real-World Study of Clinicopathologic Characteristics and Efficacy of the Malignant Mesothelioma in Chinese Population.

Chenrui Sun, Xue Yang, Lan Chen

|Sep 30, 2024
Molecular features of NSCLC patients with liver metastasis.

Jun Zhao, Jia Zhong, Yujie Chen

|Mar 26, 2024
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Jie Zhao, Wei Zhuang, Boyang Sun

|Apr 07, 2023
Detection of MET Polysomy by Next-generation Sequencing and Its Clinical Relevance for MET Inhibitors.

Boyang Sun, Tian Qiu, Xiaoling Zeng

|Sep 12, 2022
A case of multiple primary lung adenocarcinoma with a CD74-NRG1 fusion protein and HER2 mutation benefit from combined target therapy.

Kai Chen, Wen Li, Xiaoming Xi

Pageof 2

Frequent Collaborators

4 joint publications

Minglei Zhuo

4 joint publications

Xue Yang

2 joint publications

Ziping Wang

2 joint publications

Jun Zhao